Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UMP Healthcare HoldingsHKSE:00722 56 FCF Margin % is 22.35% as of Dec. 2025, which is 166% above its 10-year median of 8.41. GuruFocus rates HKSE:00722 with a GF Score™ of 56/100 and a GF Value™ of HK$0.49 (Fairly Valued). The stock has 6 warning signs investors should review. Among 666 Healthcare Providers & Services companies, UMP Healthcare Holdings ranks better than 87.09% on this metric.
The historical rank and industry rank for UMP Healthcare Holdings's FCF Margin % or its related term are showing as below:
HKSE:00722'
s FCF Margin % Range Over the Past 10 Years
Min: -21.18 Med: 8.41 Max: 23.86
Current: 15.76
During the past 11 years, the highest FCF Margin % of UMP Healthcare Holdings was 23.86%. The lowest was -21.18%. And the median was 8.41%.
HKSE:00722's FCF Margin % is ranked better than 87.09% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 3.245
vs HKSE:00722: 15.76
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00722 vs HCA, THC, DVA: FCF Margin % Comparison
For the Medical Care Facilities subindustry, UMP Healthcare Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UMP Healthcare Holdings FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, UMP Healthcare Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where UMP Healthcare Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UMP Healthcare Holdings (HKSE:00722) has a FCF Margin % of 22.35% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on UMP Healthcare Holdings and its competitors. This is 166% above median its historical median of 8.41. According to the industry distribution chart, UMP Healthcare Holdings ranks #86 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 12.9%.
Is UMP Healthcare Holdings' FCF Margin % too high?
UMP Healthcare Holdings' current FCF Margin % of 22.35% is 166% above median its 10-year median of 8.41. The Healthcare Providers & Services industry median FCF Margin % is 3.25. UMP Healthcare Holdings' value of 22.35% is 588.8% above this industry median. Based on the distribution chart, UMP Healthcare Holdings ranks #86 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, UMP Healthcare Holdings has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does UMP Healthcare Holdings' FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, UMP Healthcare Holdings ranks #86 out of 666 companies for FCF Margin %. This places UMP Healthcare Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.25. UMP Healthcare Holdings' value of 22.35% is 588.8% above this benchmark. While the company's 10-year median is 8.41 vs. the industry median of 3.25, UMP Healthcare Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.25, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UMP Healthcare Holdings's current FCF Margin % of 22.35% is 588.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on UMP Healthcare Holdings and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UMP Healthcare Holdings's current FCF Margin % is 22.35%, which is 166% above median its own 10-year median of 8.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UMP Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, UMP Healthcare Holdings (HKSE:00722) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.49, compared to a current price of HK$0.45 — trading 9.2% below its estimated fair value. The current FCF Margin % is 22.35%, which is 166% above median its 10-year median of 8.41 and 588.8% above the Healthcare Providers & Services industry median of 3.25. UMP Healthcare Holdings' overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For UMP Healthcare Holdings (HKSE:00722), the current FCF Margin % is 22.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UMP Healthcare Holdings (HKSE:00722) Overvalued in 2026?
Based on GuruFocus' analysis, UMP Healthcare Holdings stock appears to be undervalued.
The current stock price of HK$0.45 is trading 9.2% below its estimated GF Value™ of HK$0.49.
GuruFocus considers UMP Healthcare Holdings to be Fairly Valued.
Key valuation signals for HKSE:00722:
FCF Margin %: 22.35% (166% above median its 10-year median of 8.41)
GF Value™: HK$0.49 vs. price of HK$0.45 (9.2% below fair value)
Industry Position: 588.8% above the Healthcare Providers & Services median (#86 of 666)
No single metric tells the full story. See the HKSE:00722 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UMP Healthcare Holdings Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the provision of healthcare services that include corporate healthcare solution services, medical and dental services, medical imaging and laboratory services, other auxiliary medical services, and healthcare management services. The reportable operating business segments are Hong Kong & Macau Clinical Healthcare Services, which derives maximum revenue; Hong Kong & Macau Corporate Healthcare Solution Services; and Mainland China Clinical Healthcare Services. Its geographical segments include Hong Kong, Mainland China, and Macau, of which the majority of its revenue comes from Hong Kong.
56GF Score
Get the complete analysis for HKSE:00722
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00722 has been successfully added to your 
